HPQ - EGY GNS and OTLK among pre-market losers
2023-08-30 08:24:12 ET
- Outlook Therapeutics ( OTLK ) -78% .
- FibroGen ( FGEN ) -23% announces topline results from LELANTOS-2, a phase 3 clinical study of Pamrevlumab.
- Ambarella ( AMBA ) -20% after Q2 earning release .
- MasterCraft Boat Holdings ( MCFT ) -19% after Q4 earning release .
- Tivic Health Systems ( TIVC ) -14% .
- Genius Group Limited ( GNS ) -13% .
- VAALCO Energy ( EGY ) -11% .
- Box ( BOX ) -9% after Q2 earning release .
- HP ( HPQ ) -9% after Q3 earning release .
- Bionomics Limited ( BNOX ) -8% .
- GD Culture Group ( GDC ) -7% .
- Sibanye Stillwater ( SBSW ) -7% .
- LQR House ( LQR ) -6% .
- YS Biopharma ( YS ) -6% .
- Patterson Companies ( PDCO ) -5% after Q1 earning release
- UP Fintech Holding ( TIGR ) -5% reports two-year high 2023 Q2 results .
For further details see:
EGY, GNS and OTLK among pre-market losers